Proteinuria associated with anti-cancer drug use is mainly caused by damage to the glomerulus of the kidney by targeting VEGF (9, 10); for instance, bevacizumab, an anti-VEGF drug causes the event in a dose-dependent manner in 41%–63% of patients (11, 12). Here, VEGFA is linked to cancer.